PCN80 Estimating the Difference in Annual out-of-Pocket Costs for Relugolix and Leuprolide for Medicare Patients with Metastatic Prostate Cancer

Abstract

Authors

E. Borrelli C.G. McGladrigan

Full Text Cite This Article
Back to Volume 24, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×